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78Objective: Surgeons are occasionally requested to perform coronary artery bypass grafting during acute myo-
cardial infarction. We intended to test the safety of coronary artery bypass grafting and internal thoracic artery
grafting early after myocardial infarction using the Society of Thoracic Surgeons database.
Methods: The database was queried for isolated coronary artery bypass grafting less than 24 hours after a myo-
cardial infarction from 2002 to 2008. By using multivariable logistic regression and classification trees, risk
models were created to stratify this group of patients. The independent prognostic effect of internal thoracic ar-
tery grafting was examined using standard risk-adjusted mortality comparisons.
Results: A total of 44,141 patients were identified, with an overall operative mortality of 7.9%. Cardiogenic
shock occurred in 21%, percutaneous coronary intervention within 6 hours before surgery was performed in
11%, myocardial infarction within 6 hours before surgery occurred in 37%, preoperative intra-aortic balloon
pump was used in 50%, and internal thoracic artery grafting was performed in 79% of the patients. Myocardial
infarction in less than 24 hours was associated with higher operative mortality (odds ratio, 3.25) and major mor-
bidity (odds ratio, 2.54). Emergency/salvage status (odds ratio, 6.43), age more than 80 years (odds ratio, 4.07),
dialysis (odds ratio, 3.08), and cardiogenic shock (odds ratio, 2.79) were independent mortality predictors. Pa-
tients with nonemergence salvage status, absence of cardiogenic shock, creatinine less than 1.5 mg/dL, and age
less than 70 years represented 48% of the population and exhibited a lower mortality rate of 2%. Internal tho-
racic artery grafting was independently associated with a lower risk of mortality (odds ratio, 0.52; P<.0001) and
did not seem to compromise outcomes.
Conclusions: Coronary artery bypass grafting less than 24 hours after myocardial infarction carries a higher
operative risk but can be performed safely in selected patients. Although confounding variables may exist,
internal thoracic artery grafting was associated with improved outcomes. Internal thoracic artery use in this set-
ting is less than ideal, and taking time to harvest internal thoracic artery grafts in patients with acute myocardial
infarction might be encouraged. (J Thorac Cardiovasc Surg 2013;146:78-84)During the last decade, several randomized and nonrandom-
ized studies and major society guidelines have established
percutaneous coronary intervention (PCI) as the first line
of treatment for acute myocardial infarction (MI).1-8
However, situations exist in which coronary artery bypass
grafting (CABG) becomes appropriate in patients with
acute MI, for example, unsuitable coronary anatomy for
PCI, left main disease, severe 3-vessel disease, and failed
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The Journal of Thoracic and Cardiovascular Surgein these patients, but precise risk characteristics have not
been defined. Finally, in patients with acute MI and ongoing
ischemia, there is controversy whether to spend time har-
vesting the internal thoracic artery (ITA) versus performing
more rapid revascularization with a saphenous vein graft.
This study was undertaken within the Society of Thoracic
Surgeons (STS) database to investigate these issues.
MATERIALS AND METHODS
Data Source
The STS database is a voluntary program developed in 1986 to provide
risk-adjusted outcomes based on the national cardiac surgical experience. It
has expanded over the last 2 decades to represent approximately 90% of
the cardiac surgery programs in North America.9,10 Research on the STS
database is conducted by the Duke Clinical Research Institute and
approved by the Duke University Institutional Review Board. Patient
privacy is protected by standard processes in data collection and
submission established by the STS and executed by participating
institutions. Patients undergoing isolated CABG less than 24 hours after
MI were identified from January 2002 to December 2008. Patient
selection was limited to an acuity status of urgent, emergency, or
emergency/salvage. Records with missing information about age, gender,
MI, PCI, acuity status, or cardiogenic shock were excluded (<3% of
patients).ry c July 2013
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
IABP ¼ intra-aortic balloon pump
ITA ¼ internal thoracic artery
MI ¼ myocardial infarction
OR ¼ odds ratio
PCI ¼ percutaneous coronary intervention
SHOCK ¼ SHould we emergently revascularize
Occluded Coronaries for cardiogenic
shocK
STS ¼ Society of Thoracic Surgeons
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Clinical definitions for all relevant prognostic variables have been estab-
lished and can be accessed at www.sts.org. Candidate variables and coding
were consistent with the STS 2008 cardiac surgery risk models.9 Avariable
for ‘‘time trend’’ was included to adjust for temporal changes in specific
variables that may occur coincidentally with a decline in mortality rates.
To prevent identifying an unwarranted causal inference with mortality,
the STS National Coverage Determination uses ‘‘date of surgery’’ in
6-month intervals to adjust for temporal changes in the frequency of
explanatory variables and adverse outcomes.
Preoperative, operative, and postoperative variables were compared in
patients with and without MI less than 24 hours before surgery. Continuous
variables were compared with the Wilcoxon rank-sum test, and categoric
variables were compared with the Pearson chi-square test. Missing predic-
tor variables were replaced according to imputation strategies previously
established by the STS database.9 Single-effect and multiple logistic re-
gression analyses were conducted to create risk models of operative mor-
tality, including and excluding ITA grafting. Pair interactions of ITA
grafting with age, reoperation, cardiogenic shock, and acuity status were
entered in the model and tested by using the Wald statistic.
The group with MI less than 24 hours before surgery was divided into
quintiles of increasing predicted risk, and operative mortalities with and
without ITA grafting were compared within each quintile. To further ex-
clude the bias of avoiding ITA grafting in more critical patients, this com-
parison was repeated after excluding cardiogenic shock, emergency/
salvage status, and resuscitation. A classification tree was developed
from the multivariable analysis to identify subgroups with a similar mortal-
ity risk by using clinically relevant variables with the highest discrimina-
tion of operative mortality. This approach yielded subgroups with
minimal entropy subject to the constraint that each variable was split
only once, and patients in a high-risk subgroupwere not further subdivided.
The selected tree minimizes the sum of entropy in all leaves among all pos-
sible trees with the same structure.RESULTS
Patient Characteristics
From 2002 to 2008, MI less than 24 hours before surgery
was present in 7.6% of patients undergoing isolated CABG
(44,141/578,398). The baseline characteristics are shown in
Table 1. Because of the large sample size, most variables
achieved statistical significance between MI in less than
24 hours and other patients undergoing isolated CABG,
but clinically, most variables were similar between both
groups. Variables reflecting a higher acuity of presentationThe Journal of Thoracic and Cwere more prevalent in the group with an MI in less than 24
hours, such as cardiogenic shock, resuscitation, preopera-
tive intra-aortic balloon pump (IABP), inotropic use, a lower
ejection fraction, and a higher acuity status. ITA grafting
was used in 79% of the patients with MI in less than 24
hours and 90% of the patients without MI in less than 24
hours.
Outcome Comparisons
Compared with patients who did not have an MI in less
than 24 hours before CABG, operative mortality and com-
bined major morbidity and mortality were significantly
higher in the group with an MI in less than 24 hours
(7.9% vs 2.6% and 33.7% vs 16.7%, respectively). Differ-
ences in operative mortality were more pronounced as pa-
tients with an MI in less than 24 hours were further
divided into (1) MI in 6 hours or less and (2) MI in 6 to
24 hours (10.8% vs 6.3%, P<.001). ITA grafting corre-
lated with the priority of CABG, with 70.5% use in the
group with MI in 6 hours or less and 83.9% in the group
with MI in 6 to 24 hours. Of particular interest were the pa-
tients in cardiogenic shock, in whom only 56.9% received
ITA grafting. Except for deep sternal wound infection and
postoperative MI, operative morbidity was significantly
higher in the group with MI in less than 24 hours.
Selected High-Risk Categories and Univariable/
Multivariable Risk Models
Operative mortality was significantly higher in emer-
gency/salvage versus urgent status (31.7% vs 5.9%), car-
diogenic shock (22.3% vs 4%), age more than 80 years
(16.7% vs 7.1%), preoperative dialysis (23.4% vs 4.9%),
PCI in less than 6 hours (14.2% vs 7.2%), presence of
IABP (10.6% vs 5.2%), and ejection fraction less than
40% (12.9% vs 5.7%). Of note, patients not receiving
ITA grafting comprised 21% of the study population and
had an approximately 5-fold higher unadjusted mortality
compared with those receiving ITA grafting (19.1% vs
5.0%) (Table 2). Univariable analysis revealed age more
than 80 years (odds ratio [OR], 3.53), creatinine greater
than 1.5 mg/dL (OR, 3.06), congestive heart failure New
York Heart Association IV (OR, 3.55), emergency (OR,
2.67) or emergency/salvage status (OR, 13.62), cardiogenic
shock (OR, 6.68), preoperative IABP/inotropes (OR, 2.7),
ejection fraction less than 30% (OR, 2.41), mitral insuffi-
ciency (OR, 2.66), and tricuspid insufficiency (OR, 3.44)
to have the highest association with operative mortality.
Finally, ITA grafting was strongly associated with lower
operative mortality (OR, 0.22).
Multivariable logistic regression excluding ITA grafting
identified emergency/salvage status (OR, 6.43), age more
than 80 years (OR, 4.07), dialysis-dependent renal failure
(OR, 3.08), and cardiogenic shock (OR, 2.79) to have the
highest independent association with operative mortality.ardiovascular Surgery c Volume 146, Number 1 79
TABLE 1. Baseline characteristics
Characteristics MI 0-24 h No MI 0-24 h
P
value
Sample size, n, (%) 44,141 (7.6%) 534,257 (92.4%)
Demographics
Age, y, mean (IQR) 63.2 (55-72) 65.2 (57-74) <.0001
Female,% 27.0 29.0 <.0001
Caucasian,% 72.0 70.9 <.0001
Medical history
Diabetes,% 28.7 37.1 <.0001
Hypertension,% 70.1 79.6 <.0001
Hypercholesterolemia,% 62.2 76.2 <.0001
Smoker,% 57.6 56.7 <.0001
COPD (moderate/
severe),%
8.9 10.4 <.0001
Peripheral vascular
disease,%
11.8 15.5 <.0001
Cerebrovascular
disease,%
9.7 14.0 <.0001
Preoperative dialysis,% 1.1 1.9 <.0001
Immunosuppressive
treatment,%
1.8 2.3 <.0001
Congestive heart failure,% 20.2 17.1 <.0001
Prior cardiac surgery,% 4.8 6.4 <.0001
Preoperative characteristics
Serum creatinine, mg/dL,
mean (IQR)
1.15 (0.90-120) 1.18 (0.90-120) <.0001
Preoperative MI<6 h,% 37.0 0.00 <.0001
Preoperative MI 6-24 h,% 63.0 0.00 <.0001
PCI<6 h,% 10.6 0.96 <.0001
Cardiogenic shock,% 21.2 2.1 <.0001
Resuscitation,% 7.8 0.9 <.0001
Preoperative IABP,% 50.3 10.7 <.0001
Preoperative inotropes,% 12.2 2.1 <.0001
Left main disease,% 36.5 34.8 <.0001
Three vessel disease,% 75.4 76.9 <.0001
Ejection fraction,%,
mean (IQR)
43.5 (35-55) 49.9 (40-60) <.0001
Mitral regurgitation
(moderate/severe),%
3.7 3.2 <.0001
Tricuspid regurgitation
(moderate/severe),%
1.1 1.2 .004
Acuity status urgent,% 43.2 94.9 <.0001
Acuity status
emergency,%
48.9 4.7 <.0001
Acuity status
emergency/salvage,%
8.0 0.4 <.0001
(Continued)
TABLE 1. Continued
Characteristics MI 0-24 h No MI 0-24 h
P
value
Operative variables
Off-pump CABG,% 16.2 19.9 <.0001
Perfusion time, min,
mean (IQR)
101.1 (73-121) 98.1 (72-118) <.0001
Crossclamp time, min,
mean (IQR)
67.0 (46-83) 68.1 (47-84) <.0001
ITA grafting,% 79.0 90.3 <.0001
Insertion of ventricular
assist device,%
0.8 0.2 <.0001
MI, Myocardial infarction; IQR, interquartile range; COPD, chronic obstructive pul-
monary disease; PCI, percutaneous coronary intervention; IABP, intra-aortic balloon
pump; CABG, coronary artery bypass grafting; ITA, internal thoracic artery.
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original variables remained statistically significant, and ITA
grafting continued to be associated with reduced operative
mortality (OR, 0.52; confidence interval, 0.47-0.57;
P<.0001). Results of the multivariable analysis are summa-
rized in Table 3.
Interactions of ITA grafting with age, previous cardiac
operations, cardiogenic shock, and emergency/salvage80 The Journal of Thoracic and Cardiovascular Surgestatus were tested. The Wald statistic showed that the
interactions ITA*cardiogenic shock (P ¼ .058) and
ITA*reoperation (P ¼ .297) were not significant, and
thus were excluded from the model. According to these
findings, the positive effect of ITA grafting on operative
mortality did not differ significantly in patients with or
without cardiogenic shock or in patients with or without
reoperation.
Risk Stratification
After quintile risk stratification, a significant difference
in mortality was observed in each risk quintile (P<.001)
in favor of ITA grafting, except for the lowest risk quin-
tile (P ¼ .43). Similar results were obtained after exclud-
ing cardiogenic shock, emergency/salvage status, and
resuscitation. The adjusted effect of ITA grafting in the
group with MI in less than 24 hours is summarized in
Figure 1.
A classification tree identified a group of patients with an
acceptable mortality risk of 2%. The classification tree
started with 44,141 patients and was divided successively
by the following variables: emergency/salvage status (mor-
tality, 31.7%), cardiogenic shock (mortality, 16.6%), dial-
ysis or creatinine greater than 1.5 mg/dL (mortality, 9.0%),
and age more than 70 years (mortality, 6.1%). The remain-
ing patients without any of these risk factors (21,523) com-
prised 48.7% of the initial study population and had an
operative mortality of 2% (Figure 2).
DISCUSSION
Optimal selection of patients with acuteMI for surgical re-
vascularization has been an area of interest and intense
debate,2-4,11 and mortality rates have varied from 3.6%
to 23.8%.2-4,12 Current information originates primarily
from single institutional studies with low patient samples,
and results may be biased by varied institutional
preferences. To date, no data are available regarding ITA
grafting during acute MI, and the STS database represents
an opportunity to clarify details of this issue. Althoughry c July 2013
TABLE 2. Unadjusted mortality and morbidity rates and internal thoracic artery grafting in high-risk subgroups of coronary artery bypass
grafting less than 24 hours after myocardial infarction
High-risk variable Frequency,% Mortality,% Permanent stroke,% Renal failure,% Prolonged ventilation,% DSWI,% ITA,%
Cardiogenic shock
Yes 21.2 22.4 4.1 16.4 56.7 0.8 56.7
No 78.8 4.1 2.0 5.4 21.2 0.5 84.9
Age>80 y
Yes 8.8 16.7 4.0 15.5 38.6 0.6 69.0
No 91.2 7.1 2.3 7.0 27.7 0.6 79.9
Acuity status, salvage
Yes 8.0 31.7 4.2 18.1 57.4 0.8 42.8
No 92.1 5.9 2.3 6.8 26.2 0.5 82.1
Preoperative renal insufficiency
Dialysis 1.1 23.4 4.4 7.1 51.5 1.1 71.6
Creatinine>1.5 10.9 17.6 4.5 22.6 45.9 0.7 69.4
Creatinine 1.0-1.5 51.8 7.7 2.2 7.5 28.4 0.6 79.1
Creatinine<1.0 36.2 4.9 2.00 3.7 23.2 0.5 82.0
PCI<6 h
Yes 10.6 14.2 2.6 10.5 37.5 0.6 57.9
No 89.4 7.2 2.4 7.4 27.7 0.6 81.4
Preoperative MI<6 h
Yes 36.7 10.8 2.5 9.0 33.5 0.6 70.5
No 63.0 6.3 2.4 7.0 25.9 0.5 83.9
IABP
Yes 50.3 10.6 2.8 9.8 39.9 0.6 74.6
No 49.7 5.2 2.1 5.7 17.4 0.4 83.4
EF<40%
Yes 31.1 12.9 3.3 11.3 41.8 0.7 73.6
No 68.9 5.7 2.0 6.1 22.9 0.5 81.4
ITA grafting
Yes 79.0 5.0 2.1 6.1 24.5 0.6 100.0
No 21.0 19.1 3.5 14.0 44.4 0.5 0.0
DSWI, Deep sternal wound infection; ITA, internal thoracic artery; PCI, percutaneous coronary intervention; MI, myocardial infarction; IABP, intra-aortic balloon pump; EF,
ejection fraction.
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patient, perhaps some general concepts can be developed on
the basis of the nationwide experience.
Benefits of early revascularization in cardiogenic shock
have been documented in the SHould we emergently revas-
cularize Occluded Coronaries for cardiogenic shocK
(SHOCK) trial, showing a lower 6-month mortality com-
pared with initial medical stabilization (50.3% vs 63.1%,
P<.027).13 Mehta and colleagues14 found a 22%mortality
for isolated CABG during shock, with 38.8% of the patients
presenting with MI less than 24 hours before surgery. In the
present study, 21.2% of patients with MI less than 24 hours
before surgery presented in shockwith amortality of 22.3%.
The lower STS mortality may relate to different selection
criteria used in the SHOCK trial, which included a time
frame for early revascularization up to 54 hours after MI.13
Several high-risk groups were identified in the STS data
set with remarkably elevated mortality rates: emergency/
salvage status (31.7%), dialysis-dependent renal failure
(23.4%), creatinine greater than 1.5 mg/dL (17.6%), age
more than 80 years (16.7%), and PCI less than 6 hoursThe Journal of Thoracic and Cbefore surgery (14.2%). Haan and colleagues15 presented
the STS experience of PCI less than 6 hours before
CABG in the setting of MI and reported an increase in sur-
gical mortality from 13.6% to 16.3% over a decade, despite
general improvements in isolated CABG outcomes. These
ultra high-risk groups have not been addressed in previous
studies, and the suboptimal outcomes suggest that less-
invasive PCI approaches should be considered in many of
these categories whenever possible.9
Classification tree methodology in outcomes research is
a simple and valuable technique to stratify high-risk patients
and identify subpopulationswith favorable risk profiles.16-18
A substantial number of patients undergoing CABG early
after MI, showing an acceptable mortality risk, were
identified in this study (48.8% had a mortality of 2%)
(Figure 2). The patients with a surgical indication for
CABG early in the hours of an MI have not been
previously risk stratified, but a large proportion can safely
undergo operation, as required in clinical practice. This find-
ing dispels one common overgeneralization that CABG
early after MI carries a prohibitive risk. Clearly, manyardiovascular Surgery c Volume 146, Number 1 81
TABLE 3. Multivariable logistic regression model of operative
mortality (not including internal thoracic artery grafting)
Variable
Odds
ratio 95% CI
Wald
chi-square
P
value
Age 70 vs 50 y 2.21 1.80-2.73 55.70 <.0001*
Age 80 vs 50 y 4.07 3.13-5.30 108.51 <.0001*
Female vs male 1.29 1.15-1.45 19.27 <.0001*
Race, Asian 0.86 0.66-1.14 1.09 .2956
Race, Black 1.01 0.85-1.2 0.01 .9227
Race, Hispanic 1.19 0.97-1.47 2.69 .1012
Creatinine 1.5 vs 1.0 mg/dL 1.81 1.60-2.06 85.00 <.0001*
Creatinine 2.0 vs 1.0 mg/dL 1.96 1.74-2.21 122.67 <.0001*
Creatinine 2.5 vs 1.0 mg/dL 2.13 1.83-2.47 100.19 <.0001*
Dialysis vs creatinine 1.0mg/dL 3.08 2.33-4.06 63.29 <.0001*
EF 40% vs 50% 1.19 1.14-1.24 74.20 <.0001*
EF 30% vs 50% 1.41 1.31-1.53 74.20 <.0001*
BSA 1.6 vs 2.0 among male
patients
1.53 1.26-1.85 18.70 <.0001*
BSA 1.8 vs 2.0 among male
patients
1.14 1.06-1.23 13.65 .0002*
BSA 2.2 vs 2.0 among male
patients
1.02 0.98-1.07 1.03 .3091
BSA 1.6 vs 2.0 among female
patients
1.30 1.12-1.51 12.23 .0005*
BSA 1.8 vs 2.0 among female
patients
1.04 0.96-1.12 0.72 .3961
BSA 2.2 vs 2.0 among female
patients
1.17 1.02-1.34 5.35 .0207
Time trend: per 6-mo interval 0.99 0.98-1.00 6.49 .0108
Noninsulin-dependent diabetes 1.07 0.96-1.18 1.57 .2097
Insulin-dependent diabetes 1.40 1.22-1.60 23.35 <.0001*
Hypertension 0.89 0.81-0.98 6.01 .0142
Severe chronic lung disease 1.72 1.42-2.09 30.19 <.0001*
Peripheral vascular disease 1.18 1.07-1.3 10.31 .0013
CVD without CVA 1.22 1.04-1.43 5.69 .0170
CVD with CVA 1.17 1.01-1.37 4.13 .0421
Preoperative atrial fibrillation 1.2 1.03-1.39 5.6 .0179
Immunosuppressive treatment 1.39 109-1.77 7.11 .0077
Reoperation 3 1 2.35 1.63-3.38 21.24 <.0001*
PCI<6 h 1.50 1.35-1.68 52.93 <.0001*
CHF/not NYHA IV 1.03 0.89-1.20 0.20 .6586
CHF/NYHA IV 1.18 1.07-1.30 10.79 .001*
MI<6 h vs MI 6-24 h 1.05 0.97-1.14 1.64 .2010
Acuity status: emergency 2.29 1.85-2.85 56.90 <.0001*
Acuity status: emergency/
salvage
6.43 5.13-8.06 259.78 <.0001*
Cardiogenic shock 2.79 2.51-3.09 372.50 <.0001*
Preoperative IABP/inotropes 1.14 1.04-1.25 7.16 .0074
Diseased vessels (2 vs 1 or
3 vs 2)
1.07 1.00-1.25 4.01 .0453
Left main disease 1.07 0.99-1.15 2.79 .0948
Mitral insufficiency/severe 1.42 0.98-2.07 3.36 .0667
Tricuspid insufficiency:
moderate/severe
1.60 1.21-2.10 11.11 .09
CI, Confidence interval; EF, ejection fraction; BSA, body surface area; CVD, cerebro-
vascular disease; CVA, cerebrovascular accident; PCI, percutaneous coronary inter-
vention; CHF, congestive heart failure; NYHA, New York Heart Association; MI,
myocardial infarction; IABP, intra-aortic balloon pump. *P<.001.
FIGURE 1. Influence of ITA grafting on operative mortality across in-
creasing predicted risk categories after a recent MI (<24 hours). ITA, Inter-
nal thoracic artery; Qtl, quintile; OR, odds ratio.
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methods fail or the coronary anatomy is inappropriate.
The positive benefits of ITA grafting on long-term sur-
vival, freedom from cardiac events, reoperation, and graft
patency are well documented.19,20 Lower operative
mortality also has been reported in the general population
undergoing CABG.21-23 However, outcomes with ITA
grafting in the early post-MI state have not been studied,
and in the present analysis, ITA grafting in patients with
MI in less than 24 hours was associated with a halving of
operative mortality. It is conceivable that unmeasured con-
founding variables or other methodologic factors were in-
volved; however, this finding was consistent even in the
highest risk quintile, and an adjusted OR for operative mor-
tality of 0.52 is compelling. In fact, although patients post-
MI were not specifically defined, Edwards and colleagues23
presented a similar result using the STS database from 1987
to 1991 in patients undergoing general CABG. In that study,
the mortality benefits of ITA grafting seemed to increase
with baseline risk23 and to a similar degree as observed in
the present series. Thus, it is possible that ITA use is actu-
ally beneficial in this setting, and increased ITA use could
be associated with better surgical outcomes in the subgroup
with MI in less than 24 hours. Possible mechanisms include
better ITA graft function in the postischemic low-reflow
state and better early and late graft patency; however, any
of these hypotheses may err on the side of mere speculation
because the early effects of ITA grafting in this patient pop-
ulation have not been addressed in the literature. This inter-
esting finding deserves further clinical and physiologic
investigation.ry c July 2013
FIGURE 2. Classification tree for patients undergoing CABG surgery
within 24 hours of an MI (N ¼ 44,141).
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in this patient population. Of note, the rate of ITA grafting is
remarkably low in patients presenting in cardiogenic shock,
who represent 21.2% (9355 patients) of the study sample.
Although early improved outcomes with ITA grafting are
debatable, the long-term benefit is not questionable. Al-
though the low ITA use is likely related to the acuity of pre-
sentation, there is a lack of evidence in the literature to
support improved early outcomes by avoiding ITA grafting
in this patient group, approximately half of the patients in
cardiogenic shock. Our interaction analysis shows that the
outcomes in cardiogenic shock are not influenced by the
use of ITA grafting. Considering these findings, it is likely
that a large group of patients did not benefit long-term
from this conduit under the overgeneralization that ITA
grafting jeopardizes early outcomes. The implication is
that ITA grafts might be harvested, even in the sickest pa-
tients, soon after initiating cardiopulmonary bypass and
used in most post-MI situations. Although a P value of
.56 may be considered nearly significant for institutional
studies, it is largely inadequate in large-scale multi-institu-
tional registries, where minor differences can appear highlyThe Journal of Thoracic and Csignificant because of the large volume of patients included;
thus, a P value of .001 was used to test statistical signifi-
cance in our study.
A limitation of any retrospective study relates to unmea-
sured variables that can influence outcomes, such as in our
study. In the STS variable list, indications for early CABG
(<24 hours) are not well documented, and MI may have
resulted in many instances as a complication of PCI instead
of an independent coronary event. Data regarding ST-
segment elevation acute MI versus non–ST-segment eleva-
tion acute MI categories were not available in the STS data
set and might be important. The decision for surgical inter-
vention could have been biased by the various treatment
pathways and referral patterns among institutions. How-
ever, even considering these limitations, the STS database
represents a unique data set for evaluating this subject,9,10
and the findings of this analysis represent a compelling
concluding hypotheses deserving of future testing.
CONCLUSIONS
Well-documented high-risk variables are more prevalent
during acute MI, and certain patient subgroups carry a sub-
stantial mortality risk after CABG. Selected patients with
MI in less than 24 hours or in cardiogenic shock experience
acceptable mortality and may benefit from early surgical re-
vascularization. ITA grafting seems to be an effective strat-
egy in this setting, may reduce operative mortality, and is
probably underused in current practice.
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